[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Shionogi & Co. Ltd.
Shionogi & Co. Ltd. sees high social engagement with positive sentiment around AI in drug development. The company is submitting a supplemental new drug application for Ensitrelvir in Japan for COVID-19 in pediatric patients.
About Shionogi & Co. Ltd.
Shionogi & Co. Ltd. is a Japanese pharmaceutical company.
Insights #
- Shionogi & Co. Ltd. mentions is at XX which is XXX% higher than it's daily average.
- Shionogi & Co. Ltd. creators is at XX which is XXX% higher than it's daily average.
- Shionogi & Co. Ltd. engagements is up XXXXXXXX% from the previous month.
Price: $ #
Price 24-Hour Chart Data
The price volatility is likely due to a combination of high social engagement, positive sentiment around AI in drug development and COVID-19 research, alongside potential uncertainties related to clinical trials and market cap.
1-Year High: $XXXXX on 2025-06-30
1-Year Low: $XXXXX on 2024-11-20
AltRank: undefined #
AltRank 24-Hour Chart Data
Shionogi & Co. Ltd. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2024-11-21
1-Year Low: XXX on 2024-12-28
Galaxy Score: XX #
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2024-11-02
Engagements: XXX #
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXXXX
1 Week: XXXXXX +45%
1 Month: XXXXXXX +1,068%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXXX +5,796%
1-Year High: XXXXXXXXX on 2025-01-01
1-Year Low: X on 2024-08-05
| Social Network | X | TikTok | YouTube | |
|---|---|---|---|---|
| Engagements | XXX | XX | XXX | X |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX +3.40%
1 Month: XXX +10%
6 Months: XXX +398%
1 Year: XXX +233%
1-Year High: XXX on 2025-07-10
1-Year Low: X on 2024-08-03
| Social Network | X | TikTok | YouTube | |
|---|---|---|---|---|
| Mentions | XX | XX | X | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Shionogi & Co. Ltd. in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX +4.90%
1 Month: XXX +4.90%
6 Months: XXX +338%
1 Year: XXX +171%
1-Year High: XX on 2025-07-10
1-Year Low: X on 2024-08-03
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +21%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-08-07
1-Year Low: XX% on 2025-01-24
Most Supportive Themes
- AI in Drug Development: (60%) Social posts highlight the positive impact of AI in drug development, improving efficiency and reducing clinical trial times.
- PrEP for COVID-19: (30%) The social community is responding positively to Shionogi's developments in preventative measures for respiratory diseases, specifically for COVID-19.
Most Critical Themes
- Clinical Trial Concerns: (0.1%) Social posts express concerns about clinical trial methodologies.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | XX% | XXX | XX% | X | X% |
| XX | X% | XX | X% | X | X% | |
| TikTok | XXX | XX% | XX | X% | X | X% |
| YouTube | X | X% | X | X% | X | X% |
| Total | XXX | XX% | XXX | XX% | X | X% |
Market Cap: $undefined #
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXX on 2024-08-12
1-Year Low: $XXXXXXXXXXXXXXXXX on 2024-08-05
Top assets mentioned In the posts about Shionogi & Co. Ltd. in the last XX hours
Pfizer, Inc. (PFE) Alphabet Inc Class A (GOOGL)
Top topics mentioned In the posts about Shionogi & Co. Ltd. in the last XX hours
japan, approved, coins healthcare, tokyo, investment, amr, coins music, fxs, drugs, $pfe, stocks healthcare, quarterly earnings, coins ai, bloomberg, $600m, stocks, kara, thrive, med, careers, mentions, not a, nhs, acquisition, royalty, pfizer inc, $8031t, $8053t, $4768t, $4578t, $4901t, $2269t, india, help the, radar, wsj, nct, chaos and, mother of, united states, cos, australia, kenya, cov, eu, singapore, 1m, taiwan, intro, women, $googl, stocks communication services
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@SGautreau29553 @DrNeilStone Dr. Neil Stones disclosure mentions Shionogi honoraria it indicates he received compensation from Shionogi typically for consulting advisory boards or speaking engagements. It isnt funding for research per se but a professional payment the company made to him"
@gutinstinctx on X 2025-07-29 15:23:03 UTC XXX followers, XX engagements
"Shionogi & Co. Ltd. 2025 Q1 Results Earnings Call Presentation (OTCMKTS:SGIOY)"
@hardik97494342 on X 2025-07-29 13:05:03 UTC XXX followers, X engagements
"@leveredvalue @joecool20250204 @AnotherBio @thewritser @AndrewRangeley "$0.50 payable upon the first commercial sale in Japan to a third-party customer after regulatory approval for Zurzuvae in Japan by Shionogi & Co. Ltd. Sage's collaboration partner in Japan for the treatment of Major Depressive Disorder by June XX 2026." not approval alone"
@stoked_on_waves on X 2025-07-29 07:57:39 UTC 1760 followers, XX engagements
"Shionogi sees X% revenue growth in Q1FY26 revenue driven by HIV franchise royalty. The company maintained FY guidance. Acquisition of JT Group's pharmaceutical business is on track"
@Generic_Tina on X 2025-07-29 00:35:13 UTC XX followers, XX engagements